Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: Results from sinikthemba cohort, Durban, South Africa

Clinical Infectious Diseases

Volumn 49, Issue 6, 2009, Pages 956-964

  Brumme, Zabrina ^a   Wang, Bingxia ^b   Nair, Kriebashne ^c   Brumme, Chanson ^a   De Pierres, Chantal ^c   Reddy, Shabashini ^c   Julg, Boris ^a,c   Moodley, Eshia ^c   Thobakgale, Christina ^c   Lu, Zhigang ^b   Van Der Stok, Mary ^c   Bishop, Karen ^c   Mncube, Zenele ^c   Chonco, Fundisiwe ^c   Yuki, Yuko ^e   Frahm, Nicole ^a   Brander, Christian ^a   Carrington, Mary ^e   Freedberg, Kenneth ^b   Kiepiela, Photini ^c   Goulder, Philip ^a,c,d   Walker, Bruce ^a,c,f   Ndung'u, Thumbi ^a,c   Losina, Elena ^b   more..

^a HARVARD UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NATIONAL CANCER INSTITUTE   (United States)

^f HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; VIRUS PROTEIN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHRONIC DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SOUTH AFRICA; T LYMPHOCYTE ACTIVATION; VIRUS LOAD; VIRUS TYPING;

ADULT; ALLELES; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; SOUTH AFRICA; VIRAL LOAD;

EID: 70049113799     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/605503     Document Type: Article

References (39)

1. - lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-954
2. Kaslow RA, Carrington M, Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2:405-411 (Pubitemid 26193012)
3. Gao X, Nelson GW, Karacki P, et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N Engl J Med 2001;344:1668-1675 (Pubitemid 32479964)
4. Carrington M, O'Brien SJ. The influence of HLA genotype on AIDS. Annu Rev Med 2003;54:535-551
5. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-1862
6. Rodriguez B, Sethi AK, Cheruvu VK, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 2006;296:1498-1506 (Pubitemid 44465514)
7. Fellay J, Shianna KV, Ge D, et al. A whole-genome association study of major determinants for host control of HIV-1. Science 2007;317: 944-947 (Pubitemid 47301321)
8. Limou S, Le Clerc S, Coulonges C, et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis 2009; 199:419-426
9. + T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J Virol 2002; 76:2298-2305
10. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13:46-53. (Pubitemid 46067385)
11. Novitsky V, Gilbert P, Peter T, et al. Association between virus-specific T-cell responses and plasma viral load in human immunodeficiency virus type 1 subtype C infection. J Virol 2003; 77:882-890 (Pubitemid 36055510)
12. Zuniga R, Lucchetti A, Galvan P, et al. Relative dominance of Gag p24specific cytotoxic T lymphocytes is associated with human immunodeficiency virus control. J Virol 2006;80:3122-3125 (Pubitemid 43346412)
13. + T cells: correlation with viral load. J Virol 2004; 78:3233-3243
14. Geldmacher C, Currier JR, Herrmann E, et al. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremiain human immunodeficiency virus type 1-seropositive patients. J Virol 2007;81:2440-2448 (Pubitemid 46303360)
15. Tsegaye A, Ran L, Wolday D, et al. HIV-1 subtype C gag-specific Tcell responses in relation to human leukocyte antigens in a diverse population of HIV-infected Ethiopians. J Acquir Immune Defic Syndr 2007;45:389-400. (Pubitemid 47057666)
16. Klein MR, van Baalen CA, Holwerda AM, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181:1365-1372
17. Tsegaye A, Ran L, Wolday D, et al. Stable pattern of HIV-1 subtype C Gag-specific T-cell responses coincides with slow rate of CD4 T-cell decline in HIV-infected Ethiopians. AIDS 2007;21:369-372 (Pubitemid 46175051)
18. Riviere Y, McChesney MB, Porrot F, et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retroviruses 1995;11:903-907
19. Peretz Y, Tsoukas CM, Bernard NF. HIV Gag-specific immune responses predict the rate of'CD4 decline. AIDS 2008;22:1222-1224
20. Chouquet C, Autran B, Gomard E, et al. Correlation between breadth of memory HIV-specific cytotoxic T cells, viral load and disease progression in HIV infection. AIDS 2002; 16:2399-2407 (Pubitemid 35476883)
21. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLAB in mediating the potential co-evolution of HIV and HLA. Nature 2004;432:769-775 (Pubitemid 39656298)
22. Matthews PC, Prendergast A, Leslie A, et al. Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J Virol 2008;82:8548-8559
23. + T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol 2007;81:7725-7731
24. Tang J, Tang S, Lobashevsky E, et al. Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol 2002; 76:8276-8284 (Pubitemid 34809082)
25. Honeyborne I, Prendergast A, Pereyra F, et al. Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple gag-specific CD8- T-cell epitopes. J Virol 2007;81:3667-3672 (Pubitemid 46456679)
26. Jiao Y, Xie J, Li T, et al. Correlation between gag-specific CD8 T-cell responses, viral load, and CD4 count in HIV-1 infection is dependent on disease status. J Acquir Immune Defic Syndr 2006; 42:263-268 (Pubitemid 44050002)
27. Altfeld M, Addo MM, Shankarappa R, et al. Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol 2003;77:7330-7340 (Pubitemid 36734501)
28. Altteld M, Kalife ET, Qi Y, et al. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med 2006;3:e403. (Pubitemid 44721824)
29. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med 1997; 337: 1267-1274 (Pubitemid 27461281)
30. Patke DS, Langan SJ, Carruth LM, et al. Association of Gag-specific T lymphocyte responses during the early phase of human immunodeficiency virus type 1 infection and lower virus load set point. J Infect. Dis 2002;186:1177-1180
31. Ndongala ML, Peretz Y, Boulet S, et al. HIV Gag p24 specific responses secreting IFN-7 and/or IL-2 in treatment-naive individuals in acute infection early disease (AIED) are associated with low viral load. Clin Immunol 2009; 131:277-287
32. + T cells does not predict AIDS-free survival time. PLoS ONE 2008; 3:e2745.
33. Cao J, McNevin J, Holte S, Fink L, Corey L, McElrath MJ. Comprehensive analysis of human immunodeficiency virus type 1 (HIV- 1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection. J Virol 2003;77:6867-6878 (Pubitemid 36666880)
34. Gray CM, Mlotshwa M, Riou C, et al. Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point. J Virol 2009;83:470-478
35. Yang OO. Will we be able to 'spot' an effective HIV-1 vaccine? Trends Immunol 2003;24:67-72.
36. Jamieson BD, Yang OO, Hultin L, et al. Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. J Immunol 2003; 171:5372-5379 (Pubitemid 37432823)
37. Russell ND, Hudgens MG, Ha R, Havenar-Daughton C, McElrath MJ. Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. J Infect Dis 2003; 187:226-242 (Pubitemid 36132636)
38. Yang OO. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes. AIDS 2008;22:325-331
39. McElrath MJ, De Rosa SC, Moodie Z, et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 2008;372:1894-1905